Drug resistance and extended-spectrum β-lactamase (ESBLs) - producing Enterobacteriaceae, Acinetobacter and Pseudomonas species from the views of one-health approach in Ethiopia: a systematic review and meta-analysis

Table 4 Estimated ESBL-producers among gram-negative bacteria isolated from humans and the environment

Type of bacteria	Sources of isolates and estimated ESBL-production (95%CI)
Type of bacteria	Humans	Environment
E. coli	0.59 (0.46, 0.70)	0.45 (0.34, 0.56)
Klebsiella spp	0.59 (0.46, 0.70)	0.62 (0.51, 0.72)
Pseudomonas spp	0.67 (0.55, 0.77)	0.48 (0.36, 0.61)
Acinetobacter spp	0.56 (0.44, 0.68)	0.66 (0.54, 0.76)
Proteus spp	0.40 (0.31, 0.51)	0.47 (0.38, 0.56)
Citrobacter spp	0.28 (0.19, 0.39)	0.26 (0.17, 0.37)
Enterobacter spp	0.40 (0.31, 0.51)	0.10 (0.05, 0.21)
Random pooled prevalence: (95%CI), I² = % p = value	0.50 (0.39, 0.60), I² = 82.97% p = 0.000	0.43 (0.29, 0.57), I² = 91.21% p = 0.000

ISSN: 2524-4655